Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis SUNPHARMA

Max Ratio

Dividend Yield

6.74 %

5Y Dividend Growth

5.00 %

Consecutive Years

3 years

5Y Average Payout Ratio

99.22 %

Dividend History SUNPHARMA

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 6.74 %
Consecutive Years 3
Forward Annual Dividend 3.68 USD
Consistent Years 3
Dividend CAGR 3Y 1.34 %
Continuous Dividends
Dividend CAGR 5Y 0.99 %
Payout Ratio TTM 120.27 %
Dividend CAGR 10Y 5.39 %
Ex Dividend Date 10/30/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth SUNPHARMA

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin SUNPHARMA

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income SUNPHARMA

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM SUNPHARMA

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio SUNPHARMA

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Sunoco LP SUNPHARMA

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself SUNPHARMA

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 19.75
Forward PE 46.95
Enterprise Value Revenue 0.78
Price Sales TTM 0.47
Enterprise Value EBITDA 10.14
Price Book MRQ 1.86

Sunoco LP Dividends: 6.74 % Yield, History, Payment Schedule

SUNPHARMA
Current price
1 818.30 INR +9.88 INR (+0.55%)
Last closed 54.90 USD
ISIN US86765K1097
Sector Energy
Industry Oil & Gas Refining & Marketing
Exchange National Stock Exchange of India
Capitalization 10 328 350 720 USD
Yield for 12 month -1.23 %
1Y
3Y
5Y
10Y
15Y
SUNPHARMA
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+22 693 000 000 USD

Last Year

+23 068 000 000 USD

Current Quarter

+6 032 000 000 USD

Last Quarter

+5 390 000 000 USD

Current Year

+1 730 000 000 USD

Last Year

+1 178 000 000 USD

Current Quarter

+627 000 000 USD

Last Quarter

+415 000 000 USD
EBITDA 1 720 999 936 USD
Operating Margin TTM 4.23 %
Price to Earnings 19.75
Return On Assets TTM 4.30 %
PEG Ratio -3.00
Return On Equity TTM 11.75 %
Wall Street Target Price 64.25 USD
Revenue TTM 21 870 000 128 USD
Book Value 29.75 USD
Revenue Per Share TTM
Dividend Share 3.61 USD
Quarterly Revenue Growth YOY 4.90 %
Dividend Yield 6.74 %
Gross Profit TTM 2 492 999 936 USD
Earnings per share 2.78 USD
Diluted Eps TTM 2.78 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -91.40 %
Profit Margin 2.61 %

Technical Indicators SUNPHARMA

For 52 Weeks

45.62 USD 56.91 USD
50 Day MA 52.34 USD
Shares Short Prior Month 5 190 212
200 Day MA 54.04 USD
Short Ratio 5.97
Shares Short 4 612 739
Short Percent 5.31 %